{"id":"NCT02692391","sponsor":"University of Pittsburgh","briefTitle":"A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis","officialTitle":"A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2019-07-19","completion":"2019-12-30","firstPosted":"2016-02-26","resultsPosted":"2021-04-22","lastUpdate":"2021-04-22"},"enrollment":42,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Pancreatitis"],"interventions":[{"type":"DRUG","name":"Indomethacin","otherNames":["Indocin"]},{"type":"DRUG","name":"Placebo","otherNames":["Glycerin"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Indomethacin suppository","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled pilot trial seeking to evaluate the efficacy of rectal indomethacin in abrogating systemic inflammation and subsequently organ failure and mortality in patients with AP and positive SIRS score.","primaryOutcome":{"measure":"Systemic Inflammatory Response Syndrome (SIRS) Score","timeFrame":"The change in the SIRS score (48 hours - baseline)","effectByArm":[{"arm":"Placebo","deltaMin":-0.96,"sd":0.81},{"arm":"Indomethacin Suppository","deltaMin":-1,"sd":1.24}],"pValues":[{"comp":"OG000 vs OG001","p":"0.87"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["24513806","15173799","34704970"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["Acute Kidney Injury","GI Bleed"]}}